Literature DB >> 3160286

Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome.

Y Groner, J Lieman-Hurwitz, N Dafni, L Sherman, D Levanon, Y Bernstein, E Danciger, O Elroy-Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3160286     DOI： 10.1111/j.1749-6632.1985.tb21489.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  Overexpression of copper-zinc superoxide dismutase in trisomy 21.

Authors:  R De La Torre; A Casado; E López-Fernández; D Carrascosa; V Ramírez; J Sáez
Journal:  Experientia       Date:  1996-09-15

2.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

Authors:  C J Epstein; K B Avraham; M Lovett; S Smith; O Elroy-Stein; G Rotman; C Bry; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.

Authors:  C Bergeron; C Petrunka; L Weyer
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

4.  Isolation of transcribed DNA sequences from chromosome 21 using mouse fetal cDNA.

Authors:  T Yokoi; M Lovett; Z Y Cheng; C J Epstein
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

Review 5.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS.

Authors:  Pamela Milani; Stella Gagliardi; Emanuela Cova; Cristina Cereda
Journal:  Neurol Res Int       Date:  2011-04-17

Review 7.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

8.  Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.

Authors:  D Minc-Golomb; H Knobler; Y Groner
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

9.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity.

Authors:  M Schickler; H Knobler; K B Avraham; O Elroy-Stein; Y Groner
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

Review 10.  Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview.

Authors:  Marta Ferrari; Stefano Stagi
Journal:  Molecules       Date:  2021-05-24       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.